Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Racz

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
European Journal of Medical Research|February 18, 2010
HIV-induced immune activation: pathogenesis and clinical relevance - summary of a workshop organized by the German AIDS Society (DAIG e.v.) and the ICH Hamburg, Hamburg, Germany, November 22, 2008Hans-Jürgen Stellbrink, S Baldus, G Behrens, et al.
Blood|August 15, 2000
Simian immunodeficiency virus-specific cytotoxic T lymphocytes and cell-associated viral RNA levels in distinct lymphoid compartments of SIVmac-infected rhesus monkeysM J Kuroda, J E Schmitz, A Seth, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2000
Simian immunodeficiency virus (SIV)-specific CTL are present in large numbers in livers of SIV-infected rhesus monkeysJ E Schmitz, M J Kuroda, R S Veazey, et al.
AIDS Research and Human Retroviruses|February 24, 1999
Effect of complement consumption by cobra venom factor on the course of primary infection with simian immunodeficiency virus in rhesus monkeysJ E Schmitz, M A Lifton, K A Reimann, et al.
Journal of Virology|May 1, 1996
An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeysK A Reimann, J T Li, G Voss, et al.
Journal of Virology|July 25, 2000
Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infectionM A Egan, W A Charini, M J Kuroda, et al.
Tropical Medicine & International Health : TM & IH|January 9, 2007
A stepwise approach to the laboratory diagnosis of Buruli ulcer diseaseG Bretzel, V Siegmund, J Nitschke, et al.
The American Journal of Pathology|June 11, 1999
A nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibodyJ E Schmitz, M A Simon, M J Kuroda, et al.
The Journal of Experimental Medicine|September 22, 1998
The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian-human immunodeficiency virus-infected macaquesG B Karlsson, M Halloran, D Schenten, et al.
Science (New York, N.Y.)|February 5, 1999
Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytesJ E Schmitz, M J Kuroda, S Santra, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
European Journal of Medical Research|February 18, 2010
HIV-induced immune activation: pathogenesis and clinical relevance - summary of a workshop organized by the German AIDS Society (DAIG e.v.) and the ICH Hamburg, Hamburg, Germany, November 22, 2008Hans-Jürgen Stellbrink, S Baldus, G Behrens, et al.
Blood|August 15, 2000
Simian immunodeficiency virus-specific cytotoxic T lymphocytes and cell-associated viral RNA levels in distinct lymphoid compartments of SIVmac-infected rhesus monkeysM J Kuroda, J E Schmitz, A Seth, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2000
Simian immunodeficiency virus (SIV)-specific CTL are present in large numbers in livers of SIV-infected rhesus monkeysJ E Schmitz, M J Kuroda, R S Veazey, et al.
AIDS Research and Human Retroviruses|February 24, 1999
Effect of complement consumption by cobra venom factor on the course of primary infection with simian immunodeficiency virus in rhesus monkeysJ E Schmitz, M A Lifton, K A Reimann, et al.
Journal of Virology|May 1, 1996
An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeysK A Reimann, J T Li, G Voss, et al.
Journal of Virology|July 25, 2000
Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infectionM A Egan, W A Charini, M J Kuroda, et al.
Tropical Medicine & International Health : TM & IH|January 9, 2007
A stepwise approach to the laboratory diagnosis of Buruli ulcer diseaseG Bretzel, V Siegmund, J Nitschke, et al.
The American Journal of Pathology|June 11, 1999
A nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibodyJ E Schmitz, M A Simon, M J Kuroda, et al.
The Journal of Experimental Medicine|September 22, 1998
The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian-human immunodeficiency virus-infected macaquesG B Karlsson, M Halloran, D Schenten, et al.
Science (New York, N.Y.)|February 5, 1999
Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytesJ E Schmitz, M J Kuroda, S Santra, et al.
Pageof 9